Chiltern

Chiltern is a leading global contract research organization (CRO) that provides comprehensive drug development services to the pharmaceutical, biotechnology, and medical device industries. Established with a vision to enhance the efficiency of clinical trials, Chiltern has built a reputation for delivering high-quality solutions tailored to meet the unique needs of its clients.

With a strong presence in the UK and across Europe, Chiltern offers a wide range of services including:

• Clinical Development: Expert management of clinical trials from Phase I to Phase IV.
• Regulatory Affairs: Guidance through the complex regulatory landscape to ensure compliance and expedite approvals.
• Data Management: Advanced data collection and analysis to support decision-making processes.
• Biostatistics: Statistical expertise to ensure robust study designs and analyses.

Chiltern prides itself on its commitment to innovation and quality, employing cutting-edge technology and methodologies to streamline processes and improve outcomes. The company’s team of experienced professionals works collaboratively with clients to develop customized strategies that align with their specific goals.

At the heart of Chiltern’s mission is a dedication to patient safety and ethical standards, ensuring that all studies are conducted with the utmost integrity. By fostering strong partnerships with clients and stakeholders, Chiltern aims to accelerate the delivery of new therapies to market, ultimately improving patient lives.

As a forward-thinking organization, Chiltern continuously invests in talent development and technological advancements, positioning itself as a trusted partner in the evolving landscape of clinical research.